AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 1 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $343,000 | -12.5% | 145,397 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $392,000 | +24.8% | 145,397 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $314,000 | -26.3% | 145,397 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $426,000 | +10.6% | 145,397 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $385,000 | -81.2% | 145,397 | 0.0% | 0.00% | -78.6% |
| Q1 2018 | $2,047,000 | +19.7% | 145,397 | 0.0% | 0.01% | +27.3% |
| Q4 2017 | $1,710,000 | -17.1% | 145,397 | 0.0% | 0.01% | -21.4% |
| Q3 2017 | $2,063,000 | +0.8% | 145,397 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $2,046,000 | -15.7% | 145,397 | 0.0% | 0.01% | -12.5% |
| Q1 2017 | $2,427,000 | -7.8% | 145,397 | -8.8% | 0.02% | -5.9% |
| Q4 2016 | $2,633,000 | +21.2% | 159,497 | -1.9% | 0.02% | +21.4% |
| Q3 2016 | $2,173,000 | +79.7% | 162,622 | -11.0% | 0.01% | +75.0% |
| Q2 2016 | $1,209,000 | +42.6% | 182,622 | +89.9% | 0.01% | +60.0% |
| Q1 2016 | $848,000 | +265.5% | 96,167 | +416.4% | 0.01% | +400.0% |
| Q4 2015 | $232,000 | -11.5% | 18,622 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $262,000 | -66.5% | 18,622 | -83.5% | 0.00% | -66.7% |
| Q2 2015 | $783,000 | -19.1% | 112,854 | 0.0% | 0.00% | -25.0% |
| Q1 2015 | $968,000 | -1.0% | 112,854 | -13.5% | 0.00% | +33.3% |
| Q4 2014 | $978,000 | +75.3% | 130,454 | +55.8% | 0.00% | +50.0% |
| Q3 2014 | $558,000 | – | 83,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|